Signing of MoU between Egypt Healthcare authority, Novo Nordisk to enhance patient care in Hemophilia, Blood disordersby News Wires November 30, 2025On the sidelines of the Sixth Annual Forum of the General Authority for Healthcare—held this year under the patronage and ...
Prevalence and clinical management of Atherosclerotic Cardiovascular disease in patients with Type 2 diabetes across countries in the Middle East and Africa (PACT-MEA)by Gazette Staff February 8, 2024Novo Nordisk, a global pharmaceutical company specializing in diabetes, announced the results of the PACT MEA study which showed that ...
Novo Nordisk announces LE 50 bn annually to treat comorbidities caused by obesityby Gazette Staff March 15, 2021By Hamed Mahmoud Novo Nordisk Egypt announced a new study on the economic burden & cost of obesity in Egypt, ...